Molecular Cytogenetics Market Size, Share & Trends Report

Molecular Cytogenetics Market Size, Share & Trends Analysis Report By Application (Oncology, Personalized Medicine), By Technology (FISH, Immunohistochemistry, Karyotyping), By Product, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-1-68038-023-1
  • Number of Pages: 236
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the molecular cytogenetics market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for molecular cytogenetics market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of molecular cytogenetics market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Molecular Cytogenetics Market Market Categorization:

The molecular cytogenetics market was categorized into five segments, namely application (Genetic Disorders, Oncology, Personalized Medicine), technology (Comparative Genomic Hybridization, FISH, Immunohistochemistry, Karyotyping), product (Instruments, Consumables, Software & Services), end-use (Clinical & Research Laboratories, Hospitals & Path Labs, Academic Research Institutes, Pharmaceutical & Biotech Companies), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The molecular cytogenetics market was segmented into application, technology, product, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The molecular cytogenetics market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Norway; Sweden; Denmark; Japan; China; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Molecular cytogenetics market companies & financials:

The molecular cytogenetics market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • BIOVIEW , BIOVIEW develops, markets, and manufactures automated cell imaging and analysis solutions used in clinical research and testing laboratories. It has a wholly owned subsidiary in the U.S., which oversees the sales of the company's products. In 2013, Abbott Molecular also became a global distributor of the company's products based on FISH markers technology. The company develops and markets solutions, such as diagnostic equipment, with vision applications and technology for controlling motorized fluorescent and brightfield microscopes with full-resolution cameras. Currently, the company plans to market its tests for the detection of lung cancer with the help of developing a combination of biological test kits and BioView’s Target FISH application.

  • DANAHER , Danaher Corporation is multinational company actively engaged into development, manufacturing, and distribution of analytical instruments to boost research & development activities. Moreover, the company also produces diagnostic equipment and robust microscopy systems, which play a significant role in healthcare. At present, the company owns 26 subsidiaries along with a strong customer base. Around 60% of the company's revenue is generated outside the U.S. market.

  • LEICA BIOSYSTEMS NUSSLOCH GMB , Leica Biosystems Nussloch GmbH is a subsidiary of Danaher. The company develops solutions and automation for pathology labs for purposes ranging from biopsies to diagnosis. The products offered by the company range from sample preparation, staining, imaging, and reporting. Its product portfolio includes solutions and kits for histology equipment, consumables, ISH, IHC, FISH, digital pathology, research, clinical microscopy, surgery, and radiology. Its ISH, IHC, and FISH product line offers solutions for companion diagnostics.

  • AGILENT TECHNOLOGIES INC. , The company is headquartered in Santa Clara, CA, and was founded in 1999. Agilent Technologies Inc. is a worldwide leader in diagnostics, life sciences, and applied chemistry markets. The company has three major business segments: diagnostics and genomics, Agilent CrossLab, and the life sciences and applied markets. In addition to this, the company also provides instruments, software, consumables, and services to the whole laboratory workflow. Further, the company sells its products through direct sales. Along with that, they also use manufacturer's representatives' distributors, electronic commerce, and resellers.

  • ABBOTT , The company is involved in developing in vitro diagnostics, instrument systems, and tests for hospitals, reference labs, blood banks, physician offices, and clinics worldwide. It offers solutions including hematology, immunochemistry, transfusion instruments, and reagents/tests to serve fields such as cancer, cardiology, drugs of abuse/toxicology, fertility/pregnancy, infectious diseases, therapeutic drug monitoring, and transplant. It serves over 22,000 customers in 100 countries across the globe.

  • BIO-RAD LABORATORIES, INC. , Bio-Rad manufactures systems and products used in separating complex biological and chemical materials. It provides support for the identification, purification, and analysis of biological and chemical components. The company operates in two segments: clinical diagnostics and life sciences. The clinical diagnostics division develops and supplies informatics systems, test systems, quality controls, and test kits. These serve clinical laboratories in the global market. The life sciences segment is creating and discovering tools required in biological processes.

  • LLUMINA, INC. , Illumina develops, manufactures, and distributes integrated platforms and systems for sequencing. It is also involved in analyzing and investigating genomic and proteomic information, determining biological function, and gene sequence expression. The company provides Next-Generation Sequencing (NGS) genotyping, sequencing, and gene expression analysis platforms. It operates mainly in North America and Europe. It is involved in developing novel sequencing technologies aimed at reducing the cost of sequencing whole genomes.

  • OXFORD GENE TECHNOLOGY , Oxford Gene Technology is a provider of biomarker and genetic research solutions to molecular biologists and cytogenetics research institutions. CytoSure, microarrays manufactured by the company, are applicable in cytogenetic research. The company has a staff strength of 100 people. Oxford Gene Technology (OGT) mainly deals in genomic research. The company provides FISH probes for detection of ovarian cancer, inherited genetic diseases, and solid tumor panels. Some of the company's key licensees are Affymetrix, Agilent Technologies, Inc.; Biotype Diagnostic GmbH, Illumina, Inc., Invitrogen, and Phalanx Biotech Group. The Company's distributors are Bulgaria, China, Israel, Italy, Japan, Jordan, Malaysia, and Turkey.

  • F. HOFFMANN-LA ROCHE LTD. , F. Hoffmann-La Roche Ltd is involved in developing and manufacturing diagnostic and pharmaceutical products. The company has 26 manufacturing sites across the globe. It operates in two segments: pharmaceuticals and diagnostics. The pharmaceutical segment manufactures drugs for infectious, cardiovascular, respiratory, oncology, metabolic disorders, central nervous system, and autoimmune diseases.

  • PERKIN ELMER, INC. , VIEW PerkinElmer, Inc. provides solutions, services, and technology to research, industrial, environmental, diagnostics, & laboratory service markets. The company's product offerings include genetic testing and diagnostic tools, analytical instruments, medical imaging products, software, consumables, and instruments. It caters to various industries, including chemicals, consumer and food product safety, energy, environmental analysis, healthcare, food beverage and nutraceuticals, forensics, and life sciences.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Molecular Cytogenetics Market Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Molecular Cytogenetics Market Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon